Description
March 27, 2026
CAP Foundation Informatics Travel Award
Running on Empty: Scarcity Shortages and the Future of Care (CAP Foundation)
Hosted on Ausha. See ausha.co/privacy-policy for more information.








Description
March 27, 2026
CAP Foundation Informatics Travel Award
Running on Empty: Scarcity Shortages and the Future of Care (CAP Foundation)
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A legislative win in West Virginia, a travel opportunity for residents, and the challenge of practicing pathology in a low-income country. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, March 27th. A West Virginia bill that could have disrupted routine practices by pathologists and clinical laboratories failed to pass the legislature this session. The West Virginia Association of Pathologists and the CAP opposed the Genetic Information Privacy Act because it lacked an explicit exemption for legitimate medical use. Pathologists and labs that collect, use, and disclose genetic data could have faced legal risk had the bill become law. The CAP and state pathology societies continue to advocate for strengthened HIPAA exemptions to protect pathologists' medical access and patients' access to timely care. Meanwhile, what do U.S. laboratories look for when choosing tests? A study published in the CAP's Archives of Pathology and Laboratory Medicine looks at this question. Almost all the labs said the most important factor when choosing any test is assay coverage of specific variants and or positions of interest. The study looked at both lab-developed tests or LDTs, regulated by the Centers for Medicare and Medicaid Services, and in vitro diagnostic products, IVDs, which are regulated by the FDA. Labs using LDTs said the most important fact is flexibility to modify the assay, while labs using IVDs ranked the reputation of the assay manufacturer and customer service support as most important. Pathology residents can apply to receive funding to attend CAP26, the CAP's annual meeting in Las Vegas, October 3rd through the 6th. The CAP Foundation's Informatics Travel Award provides up to $1,200 to defray travel and hotel expenses for residents who agree to attend informatics-based educational sessions. The award is open to residents only, and the application deadline is April 7th. Finally, pathologists face many challenges here in the U.S., but imagine practicing in a low-income country I'm sorry. with limited funding, supply chains, and staffing levels. That was the focus of the latest CAP Foundation podcast, Beyond the Test, Connecting Communities Through Pathology. It featured Dr. Danny Milner, Jr., Chair of Pathology at Olive View UCLA Medical Center in Los Angeles, and former Chief Medical Officer of the American Society for Clinical Pathology. He has worked extensively. to support pathologists in low-income countries. He said two of the hardest problems to solve, not enough pathologists to handle caseloads, and a lack of essential reagents.
What they stock out of are reagents for immunistic chemistry, reagents for special stains, which, as you know, in some diseases are crucial for being able to even make a diagnosis, right? Breast cancer, you wouldn't even move a muscle without ERPR HER2-KI67. to direct you through immunochemistry to how that patient should be treated. So, you know, that's where we have a lot of stress put on those types of facilities because they don't have the answer. They can't give a complete answer and it's out of their control, right? Because they don't have the reagents.
Nonprofits, including the CAP Foundation, are helping provide more resources. Dr. Milner described a more basic way those in the U.S. can support their colleagues overseas.
On the simple side, being appreciated and that knowing that when they make a diagnosis, a patient's life is being saved. I think that that kind of constant reinforcement of why we're here and why we do this, which is what we get every day in the US. I think people don't often get it in low-income countries. And so that's something simple that we can all do is help them feel appreciated and know that they are helping patients do that.
And that does it for us today. For more information on today's stories, check the show notes. And watch your email inbox for more news like this in the CAP's Advocacy Newsletter every Tuesday and our weekly edition newsletter on Thursdays. We're back. Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great weekend.
Description
March 27, 2026
CAP Foundation Informatics Travel Award
Running on Empty: Scarcity Shortages and the Future of Care (CAP Foundation)
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A legislative win in West Virginia, a travel opportunity for residents, and the challenge of practicing pathology in a low-income country. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, March 27th. A West Virginia bill that could have disrupted routine practices by pathologists and clinical laboratories failed to pass the legislature this session. The West Virginia Association of Pathologists and the CAP opposed the Genetic Information Privacy Act because it lacked an explicit exemption for legitimate medical use. Pathologists and labs that collect, use, and disclose genetic data could have faced legal risk had the bill become law. The CAP and state pathology societies continue to advocate for strengthened HIPAA exemptions to protect pathologists' medical access and patients' access to timely care. Meanwhile, what do U.S. laboratories look for when choosing tests? A study published in the CAP's Archives of Pathology and Laboratory Medicine looks at this question. Almost all the labs said the most important factor when choosing any test is assay coverage of specific variants and or positions of interest. The study looked at both lab-developed tests or LDTs, regulated by the Centers for Medicare and Medicaid Services, and in vitro diagnostic products, IVDs, which are regulated by the FDA. Labs using LDTs said the most important fact is flexibility to modify the assay, while labs using IVDs ranked the reputation of the assay manufacturer and customer service support as most important. Pathology residents can apply to receive funding to attend CAP26, the CAP's annual meeting in Las Vegas, October 3rd through the 6th. The CAP Foundation's Informatics Travel Award provides up to $1,200 to defray travel and hotel expenses for residents who agree to attend informatics-based educational sessions. The award is open to residents only, and the application deadline is April 7th. Finally, pathologists face many challenges here in the U.S., but imagine practicing in a low-income country I'm sorry. with limited funding, supply chains, and staffing levels. That was the focus of the latest CAP Foundation podcast, Beyond the Test, Connecting Communities Through Pathology. It featured Dr. Danny Milner, Jr., Chair of Pathology at Olive View UCLA Medical Center in Los Angeles, and former Chief Medical Officer of the American Society for Clinical Pathology. He has worked extensively. to support pathologists in low-income countries. He said two of the hardest problems to solve, not enough pathologists to handle caseloads, and a lack of essential reagents.
What they stock out of are reagents for immunistic chemistry, reagents for special stains, which, as you know, in some diseases are crucial for being able to even make a diagnosis, right? Breast cancer, you wouldn't even move a muscle without ERPR HER2-KI67. to direct you through immunochemistry to how that patient should be treated. So, you know, that's where we have a lot of stress put on those types of facilities because they don't have the answer. They can't give a complete answer and it's out of their control, right? Because they don't have the reagents.
Nonprofits, including the CAP Foundation, are helping provide more resources. Dr. Milner described a more basic way those in the U.S. can support their colleagues overseas.
On the simple side, being appreciated and that knowing that when they make a diagnosis, a patient's life is being saved. I think that that kind of constant reinforcement of why we're here and why we do this, which is what we get every day in the US. I think people don't often get it in low-income countries. And so that's something simple that we can all do is help them feel appreciated and know that they are helping patients do that.
And that does it for us today. For more information on today's stories, check the show notes. And watch your email inbox for more news like this in the CAP's Advocacy Newsletter every Tuesday and our weekly edition newsletter on Thursdays. We're back. Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great weekend.
Share
Embed
You may also like
Description
March 27, 2026
CAP Foundation Informatics Travel Award
Running on Empty: Scarcity Shortages and the Future of Care (CAP Foundation)
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A legislative win in West Virginia, a travel opportunity for residents, and the challenge of practicing pathology in a low-income country. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, March 27th. A West Virginia bill that could have disrupted routine practices by pathologists and clinical laboratories failed to pass the legislature this session. The West Virginia Association of Pathologists and the CAP opposed the Genetic Information Privacy Act because it lacked an explicit exemption for legitimate medical use. Pathologists and labs that collect, use, and disclose genetic data could have faced legal risk had the bill become law. The CAP and state pathology societies continue to advocate for strengthened HIPAA exemptions to protect pathologists' medical access and patients' access to timely care. Meanwhile, what do U.S. laboratories look for when choosing tests? A study published in the CAP's Archives of Pathology and Laboratory Medicine looks at this question. Almost all the labs said the most important factor when choosing any test is assay coverage of specific variants and or positions of interest. The study looked at both lab-developed tests or LDTs, regulated by the Centers for Medicare and Medicaid Services, and in vitro diagnostic products, IVDs, which are regulated by the FDA. Labs using LDTs said the most important fact is flexibility to modify the assay, while labs using IVDs ranked the reputation of the assay manufacturer and customer service support as most important. Pathology residents can apply to receive funding to attend CAP26, the CAP's annual meeting in Las Vegas, October 3rd through the 6th. The CAP Foundation's Informatics Travel Award provides up to $1,200 to defray travel and hotel expenses for residents who agree to attend informatics-based educational sessions. The award is open to residents only, and the application deadline is April 7th. Finally, pathologists face many challenges here in the U.S., but imagine practicing in a low-income country I'm sorry. with limited funding, supply chains, and staffing levels. That was the focus of the latest CAP Foundation podcast, Beyond the Test, Connecting Communities Through Pathology. It featured Dr. Danny Milner, Jr., Chair of Pathology at Olive View UCLA Medical Center in Los Angeles, and former Chief Medical Officer of the American Society for Clinical Pathology. He has worked extensively. to support pathologists in low-income countries. He said two of the hardest problems to solve, not enough pathologists to handle caseloads, and a lack of essential reagents.
What they stock out of are reagents for immunistic chemistry, reagents for special stains, which, as you know, in some diseases are crucial for being able to even make a diagnosis, right? Breast cancer, you wouldn't even move a muscle without ERPR HER2-KI67. to direct you through immunochemistry to how that patient should be treated. So, you know, that's where we have a lot of stress put on those types of facilities because they don't have the answer. They can't give a complete answer and it's out of their control, right? Because they don't have the reagents.
Nonprofits, including the CAP Foundation, are helping provide more resources. Dr. Milner described a more basic way those in the U.S. can support their colleagues overseas.
On the simple side, being appreciated and that knowing that when they make a diagnosis, a patient's life is being saved. I think that that kind of constant reinforcement of why we're here and why we do this, which is what we get every day in the US. I think people don't often get it in low-income countries. And so that's something simple that we can all do is help them feel appreciated and know that they are helping patients do that.
And that does it for us today. For more information on today's stories, check the show notes. And watch your email inbox for more news like this in the CAP's Advocacy Newsletter every Tuesday and our weekly edition newsletter on Thursdays. We're back. Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great weekend.
Description
March 27, 2026
CAP Foundation Informatics Travel Award
Running on Empty: Scarcity Shortages and the Future of Care (CAP Foundation)
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A legislative win in West Virginia, a travel opportunity for residents, and the challenge of practicing pathology in a low-income country. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, March 27th. A West Virginia bill that could have disrupted routine practices by pathologists and clinical laboratories failed to pass the legislature this session. The West Virginia Association of Pathologists and the CAP opposed the Genetic Information Privacy Act because it lacked an explicit exemption for legitimate medical use. Pathologists and labs that collect, use, and disclose genetic data could have faced legal risk had the bill become law. The CAP and state pathology societies continue to advocate for strengthened HIPAA exemptions to protect pathologists' medical access and patients' access to timely care. Meanwhile, what do U.S. laboratories look for when choosing tests? A study published in the CAP's Archives of Pathology and Laboratory Medicine looks at this question. Almost all the labs said the most important factor when choosing any test is assay coverage of specific variants and or positions of interest. The study looked at both lab-developed tests or LDTs, regulated by the Centers for Medicare and Medicaid Services, and in vitro diagnostic products, IVDs, which are regulated by the FDA. Labs using LDTs said the most important fact is flexibility to modify the assay, while labs using IVDs ranked the reputation of the assay manufacturer and customer service support as most important. Pathology residents can apply to receive funding to attend CAP26, the CAP's annual meeting in Las Vegas, October 3rd through the 6th. The CAP Foundation's Informatics Travel Award provides up to $1,200 to defray travel and hotel expenses for residents who agree to attend informatics-based educational sessions. The award is open to residents only, and the application deadline is April 7th. Finally, pathologists face many challenges here in the U.S., but imagine practicing in a low-income country I'm sorry. with limited funding, supply chains, and staffing levels. That was the focus of the latest CAP Foundation podcast, Beyond the Test, Connecting Communities Through Pathology. It featured Dr. Danny Milner, Jr., Chair of Pathology at Olive View UCLA Medical Center in Los Angeles, and former Chief Medical Officer of the American Society for Clinical Pathology. He has worked extensively. to support pathologists in low-income countries. He said two of the hardest problems to solve, not enough pathologists to handle caseloads, and a lack of essential reagents.
What they stock out of are reagents for immunistic chemistry, reagents for special stains, which, as you know, in some diseases are crucial for being able to even make a diagnosis, right? Breast cancer, you wouldn't even move a muscle without ERPR HER2-KI67. to direct you through immunochemistry to how that patient should be treated. So, you know, that's where we have a lot of stress put on those types of facilities because they don't have the answer. They can't give a complete answer and it's out of their control, right? Because they don't have the reagents.
Nonprofits, including the CAP Foundation, are helping provide more resources. Dr. Milner described a more basic way those in the U.S. can support their colleagues overseas.
On the simple side, being appreciated and that knowing that when they make a diagnosis, a patient's life is being saved. I think that that kind of constant reinforcement of why we're here and why we do this, which is what we get every day in the US. I think people don't often get it in low-income countries. And so that's something simple that we can all do is help them feel appreciated and know that they are helping patients do that.
And that does it for us today. For more information on today's stories, check the show notes. And watch your email inbox for more news like this in the CAP's Advocacy Newsletter every Tuesday and our weekly edition newsletter on Thursdays. We're back. Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great weekend.
Share
Embed
You may also like